Seattle Biotech Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Seattle Biotech

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (7)	3/18/2000 10:22:00 PM
From: Mike McFarland	Read Replies (1) of 70

March 14, 2000-Seattle Genetics, Inc., has raised $30 million in private financing to fight cancer. seattlegenetics.com Targeted Genetics: AIDS vaccine push centered in Seattle NIH focuses effort on widespread patient trials seattlep-i.com I'm sure most of these technologies will be in place within five years," said Phil Greenberg, a professor of medicine and immunology at the University of Washington and a virologist at the Hutchinson Center. "Certainly, we will be testing in clinical models (patient trials) within the next five years. Greenberg seemed familiar, so I hit google with this... google.com In November of 1998, a patent covering the REM technology was issued to Drs. Stan Riddell and Phil Greenberg at the Fred Hutchinson Cancer Research Center in Seattle. This patent is licensed exclusively to Targeted Genetics. noonanrusso.com I wonder if REM will end up playing a role in this HIV vaccine work?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next